Human herpesvirus 6A induces apoptosis of primary human fetal astrocytes via both caspase-dependent and -independent pathways
- Bin Gu1, 2,
- Guo-Feng Zhang1, 2,
- Ling-Yun Li2,
- Feng Zhou2,
- Dong-Ju Feng2,
- Chuan-Lin Ding3,
- Jing Chi2,
- Chun Zhang1, 2,
- Dan-Dan Guo2,
- Jing-Feng Wang2,
- Hong Zhou2,
- Kun Yao2Email author and
- Wei-Xing Hu1Email author
© Gu et al.; licensee BioMed Central Ltd. 2011
Received: 3 August 2011
Accepted: 12 December 2011
Published: 12 December 2011
Human herpesvirus 6 (HHV-6) is a T-lymphtropic and neurotropic virus that can infect various types of cells. Sequential studies reported that apoptosis of glia and neurons induced by HHV-6 might act a potential trigger for some central nervous system (CNS) diseases. HHV-6 is involved in the pathogenesis of encephalitis, multiple sclerosis (MS) and fatigue syndrome. However, the mechanisms responsible for the apoptosis of infected CNS cells induced by HHV-6 are poorly understood. In this study, we investigated the cell death processes of primary human fetal astrocytes (PHFAs) during productive HHV-6A infection and the underlying mechanisms.
HHV-6A can cause productive infection in primary human fetal astrocytes. Annexin V-PI staining and electron microscopic analysis indicated that HHV-6A was an inducer of apoptosis. The cell death was associated with activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase (PARP), which is known to be an important substrate for activated caspase-3. Caspase-8 and -9 were also significantly activated in HHV-6A-infected cells. Moreover, HHV-6A infection led to Bax up-regulation and Bcl-2 down-regulation. HHV-6A infection increased the release of Smac/Diablo, AIF and cytochrome c from mitochondria to cytosol, which induced apoptosis via the caspase-dependent and -independent pathways. In addition, we also found that anti-apoptotic factors such as IAPs and NF-κB decreased in HHV-6A infected PHFAs.
This is the first demonstration of caspase-dependent and -independent apoptosis in HHV-6A-infected glial cells. These findings would be helpful in understanding the mechanisms of CNS diseases caused by HHV-6.
KeywordsApoptosis Human herpesvirus 6A Primary human fetal astrocyte Caspase
Human herpesvirus 6
Central nervous system
Acquired immunodeficiency syndrome
Primary human fetal astrocyte
Bcl-2 associated X protein
B cell lymphoma 2
Apoptotic protease activating factor 1
Inhibitor of apoptosis protein
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
Nuclear factor kappa B
Poly (ADP-ribose) polymerase
- TNF- α:
Human herpesvirus 6 (HHV-6), a member of the beta herpesvirus family, is a T-lymphotropic virus and the causal agent of exanthema subitum [1–3]. In recent studies, HHV-6 has been detected in numerous central nervous system (CNS) diseases including encephalitis, multiple sclerosis, temporal lobe epilepsy and glioma [4–7]. These findings suggest that HHV-6 may be associated with some CNS diseases. In vitro, HHV-6 has been shown to infect human glial cells (microglia, oligodendrocytes and astrocytes) and induce apoptosis [8–10]. However, the molecular mechanisms of apoptosis induced by HHV-6 in glial cells are not fully understood as yet.
Apoptosis, a programmed suicide death of cells, which is characterized by chromatin condensation, DNA fragmentation, membrane blebbing, and cell shrinkage, can occur through the intrinsic and extrinsic casepase pathways . Caspases, a family of cysteine proteases, regulate the initiation and the final execution of apoptosis in receptor-mediated and mitochondria-mediated pathways . In the receptor-mediated pathway, caspase-8 is the initiator caspase that can directly activate the final executioner caspase-3 . In the mitochondria-mediated pathway, mitochondria release several pro-apoptotic factors including cytochrome c, Smac/Diablo, and apoptosis-inducing factor (AIF) into the cytosol . Cytosolic cytochrome c binds with apoptotic protease activating factor 1 (APAF1) to produce active caspase-9 and subsequently active caspase-3 for caspase-dependent apoptosis. Samc/Diablo is an antagonistic protein for inhibitor of apoptosis proteins (IAPs), promotes apoptosis along with cytochrome c by activating caspases . Mitochondria-mediated apoptosis may also occur in caspase-independently way after mitochondrial release of AIF that is translocated to the nucleus for induction of chromatin condensation and DNA fragmentation .
In the present study, we investigated the effect and molecular mechanism of HHV-6A inducing apoptosis in primary human fetal astrocytes (PHFAs). We found that HHV-6A induced apoptosis in PHFAs through both caspase-dependent and -independent apoptotic pathways. In addition, our finding also demonstrated that HHV-6A could promote cell death by suppressing IAPs and NF-κB-mediated anti-apoptosis pathways. To our knowledge, this is the first demonstration of the mechanisms of apoptosis induced by HHV-6A in astrocytes.
HHV-6A causes productive infection in PHFAs
HHV-6A induces apoptosis of PHFAs
HHV-6A triggers caspases activation
HHV-6A activates PARP cleavage and up-regulates bax/bcl-2 ratio
The mitochondria-mediated pathway of apoptosis is regulated by the Bcl-2 family proteins, which are known to directly regulate mitochondrial membrane permeability. We examined the levels of expression of Bax (pro-apoptotic) and Bcl-2 (anti-apoptotic) proteins using Western blotting analysis. As shown in Figure 4b, the levels of Bcl-2 protein were significantly decreased following HHV-6A infection compared to that in mock-infected cells, whereas the expression of Bax protein was significantly increased in HHV-6A-infected cells. These results indicate Bax/Bcl-2 ratio was significantly increased in HHV-6A-infected cells compared with mock-infected cells.
HHV-6A infection results in the release of pro-apoptotic proteins from mitochondria
HHV-6A suppresses IAPs and NF-κB-mediated anti-apoptosis effect
NF-κB plays a crucial role not only in immunity, inflammation and cell migration but also in cell survival and apoptosis. Many studies confirmed that NF-κB up-regulation and activation exerted an anti-apoptotic effect leading to cells survival, transformation, and resistance to radiation and chemotherapy . As shown in Figure 6, the levels of NF-κB were significantly decreased in HHV-6A-infected cells compared to that in mock-infected cells, while the expression of NF-κB inhibitor-IκBα protein was significantly increased in HHV-6A-infected cells. These results indicate that HHV-6A infection injures IAPs and NF-κB-mediated anti-apoptosis signal pathways in PHFAs.
HHV-6 was first isolated from peripheral blood mononuclear cells of patients with lymphoproliferative disorders and AIDS . There are two variants of HHV-6 (A and B) according to distinct genetic, immunological and virological characteristics . As with other virus, HHV-6 is able to induce apoptosis of host cells. Subsequent studies have demonstrated that HHV-6 has been shown to induce apoptosis in astrocytes, oligodendrocytes, neuronal cell lines and CD4+ T lymphocytes [8, 19, 20]. Gardell et al.  reported that HHV-6A induced apoptosis by an unknown mechanism in astrocytes, oligodendrocytes and neuronal cell lines. Inoue et al.  demonstrated that TNF-α and anti-Fas antibodies augmented HHV-6-induced apoptosis, suggesting an involvement bof death receptors in HHV-6-induced apoptosis. In contrast, Inchimi et al.  found that HHV-6 induced apoptosis of cord blood lymphocytes through a receptor-independent pathway.
Caspases play a critical role in apoptosis, which cleave specific substrates and activate downstream molecules and culminate in cell death [11, 13]. However, the roles of caspases in HHV-6-induced apoptosis of astrocytes haven't been studied yet. In this study, we demonstrated that the activities of caspase-3, -8 and -9 were all increased in HHV-6A-induced apoptosis of PHFAs. In addition, we found that PARP was cleaved in HHV-6A-induced apoptotic PHFAs. Caspase-3 is a common effector of both death receptor and the mitochondrial signaling pathways. Caspase-8 is activated by the death receptor signaling pathway, whereas caspase-9 is activated in the mitochondrial signaling pathway during apoptosis. We speculate that HHV-6A-induced apoptosis in astrocytes via both caspase-dependent receptor and mitochondrial apoptotic pathways.
Bcl-2 family proteins are central regulators of the mitochondrial apoptotic pathway and have been implicated in various models of virus-induced apoptosis. Pugazhenthi et al.  found that simian varicella virus induced apoptosis in monkey kidney cells via caspase-dependent mitochondrial pathway and involves down-regulation of bcl-2 expression. The translocation and accumulation of Bax, a pro-apoptotic factor of Bcl-2 family in mitochondria will lead to release of cytochrome c and AIF . We examined the expression of Bcl-2 and Bax in HHV-6A-induced mitochondrial dysfunction. Our data showed that the anti-apoptotic protein Bcl-2 decreased, which was accompanied by the increase of pro-apoptotic protein Bax during HHV-6A infection, suggesting that Bcl-2 and Bax were involved in the apoptosis of HHV-6A-infected PHFAs.
Up-regulation of Bax induces the permeabilization of mitochondrial outer membrane and initiates mitochondrial dysfunction. Mitochondria may release several molecules including cytochrome c, Smac/Diablo, and AIF to induce apoptosis via the caspase-dependent and -independent pathways [24–26]. We separated the cytosolic and mitochondrial fractions to examine the cytochrome c levels by Western blotting and found a marked increase in cytochrome c level in the cytosolic fraction due to a concomitant decrease in the cytochrome c level in the mitochondrial fraction following HHV-6A infection. Mitochondrial cytochrome c releases into cytoplasm to bind to the apoptosis protease activation factor (APAF1) and to form a complex of apoptosome activating pro-caspase 9. The activation of pro-caspase 9 initiates an enzymatic reaction cascade leading to the execution of apoptosis in cells . We also observed a time-dependent increase the cytosolic level of Smac/Diablo following infection compared with control cells. Smac/Diablo can inhibit inhibitor-of-apoptosis-proteins (IAPs), which otherwise inactivate caspases . Mitochondria-mediated apoptosis may also occur caspase-independently after mitochondrial release of AIF and Endo G which are translocated to the nucleus for induction of chromatin condensation and DNA fragmentation. Our investigation demonstrated that HHV-6A markedly increased the cytosolic level of AIF in PHFAs, indicating involvement of caspase-independent pathway of apoptosis .
In addition, NF-κB reportedly induces the expression of c-IAP1, c-IAP2 and XIAP, thereby promoting NF-κB activation in a positive feed-back system . NF-κB up-regulation exerts an anti-apoptotic effect leading to cells survival, transformation, and resistance to radiation and drug therapies . In contrast, NF-κB down-regulation will break this feed-back loop and reduce the expression of c-IAP1, c-IAP2 and XIAP, which are the direct caspase inhibitors. In the present study, we found that HHV-6A decreased NF-κB and increased Iκ-Bα expression in time-dependent manners. IκBα is one member of the family of cellular proteins that function to inhibit the activity of NF-κB. IκBα inhibits NF-κB by masking the nuclear localization signals of NF-κB proteins and keeping them sequestered in an inactive state in the cytoplasm. IκBα up-regulation may inhibit the activity of NF-κB which was observed down-regulation in HHV-6A-infected PHFAs. We also found that HHV-6A decreased expression of c-IAP1, c-IAP2 and XIAP. Increased mitochondrial release of Smac/Diablo could antagonize IAPs expression. Suppression of survival factors such as IAPs and NF-κB could be due to cytosolic up-regulation of Smac/Diablo .
We demonstrated that HHV-6A induces cell apoptosis in PHFAs through both caspase-dependent and -independent apoptosis pathways, as evidenced by (1) activation of caspase-3, -8 and -9; (2) increasing the ratio of Bax/Bcl-2; (3) increasing the presence of Smac/Diablo, AIF and cytochrome c in cytoplasm; (4) down-regulation of anti-apoptotic NF-κB and IAPs. The identification of the apoptotic signaling pathways in HHV-6A-infected PHFAs would be very helpful in understanding the mechanisms by which HHV-6A infection causes diseases in the CNS.
Materials and methods
Cells and viruses
The primary human fetal astrocytes (Sciencell) were cultured in DEME/F12 (Hyclone) supplemented with 10% fetal calf serum, 100 IU/ml penicillin/streptomycin (Invitrogen). Human T-cell line HSB-2 cells were cultured in RPMI 1640 medium containing 8% fetal calf serum. HHV-6A strain GS was inoculated into HSB-2 cells. The cells were frozen and thawed twice when 80% of HHV-6A-infected HSB-2 cells showed the cytopathic effects (CPE), then centrifuged at 2000 × g for 10 min. The supernatants were stored at -70°C as cell-free virus. Viral DNA equivalents of the frozen aliquot were tested by quantitative PCR. Uninfected HSB-2 cells were similarly cultured and treated using the same procedure and used for mock infection. For infection, 3 × 105 primary human fetal astrocytes (PHFAs) were seeded onto a poly-L-lysine (Sigma)-coated 25-cm2 flask (Corning). After an overnight incubation, the plate was washed three times with phosphate-buffered saline (PBS) and infected with cell-free supernatant containing 108 viral DNA copies/106 PHFAs. After 3 h incubation at 37°C in 5% CO2, cultures were washed three times with PBS, and fresh medium was added. The HHV-6A-infected cells were checked for CPE every day in microscopy. Procedures for mock infection were performed in the same manner as for viral infection.
Immunofluorescence assay (IFA)
PHFAs were cultured on poly-L-lysine-coated 2-chamber glass slides, and the infection was performed as described above. The procedure of immunofluorescence assay has previously been described . Briefly, PHFAs infected with or without HHV-6A were fixed in 4% paraformaldehyde (in PBS), permeabilized in 0.5% Triton X-100 (in PBS), and stained with the anti-gp60/110 monoclonal antibodies (Chemicon international) followed by secondary antibody labeled with fluorescein isothiocyanate (FITC).
Cells were fixed with 2.5% glutaradehyde at room temperature for 1 h. After washing with PBS, the cells were collected, dehydrated in a series of 70%, 80% and 90% ethanol, and embedded in Epon. Ultrathin sections were cut and mounted in nickel grids, stained with uranyl acetate and lead citrate, and examined by a transmission electron microscopy.
Annexin V-propidium iodide (PI) staining
Apoptosis was measured by Annexin V-propidium iodide (PI) staining and flow cytometry. Infected and uninfected PHFAs were trypsinized, washed in PBS and incubated with Annexin V-FITC and PI solution (Bender MedSystems, Burlingame) in the dark for 15 min. Samples were analyzed by flow cytometry with FACSCalibur and BD CellQuest Pro software (Becton Dickinson, Mountain View). The amount of early apoptosis and late apoptosis was determined as the percentage of Annexin V+/PI- and Annexin V+/PI+, respectively.
Analysis of activated caspase-3 by flow cytometry
Caspase-3 activities in HHV-6A-infected and mock-infected PFHA were tested by flow cytometry with FITC-DEVD-FMK that recognizes cleaved caspase-3 according to the protocol by the manufacturer (Biovision Inc.).
Analysis of caspase-8 and caspase-9 using a colorimetric method
The activation of caspase-8 and caspase-9 was analyzed using a colorimetric assay kit (KeyGEN). Briefly, mock-infected and HHV-6A-infected PFHA were collected and resuspended in 50 μl of lysis buffer and incubated on ice for 30 min. After centrifugation, the protein concentration was assayed by the BCA Protein Assay kit (Byotime), and 50 μg protein was diluted in 50 μl lysis buffer for each assay. Then 5 μl of casepase-8 or caspase-9 substrate were added, respectively. The reaction mixture was incubated at 37°C for 4 h. The released chromphore was measured at 405 nm by a microplate reader.
Preparation of cytosolic and mitochondrial extracts
Cells were washed twice with PBS and kept for 1 h in ice-cold hypotonic buffer (20 mM HEPES, pH7.4, 1.5 mM MgCl2, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin, aprotinin and pepstatin) containing 250 mM sucrose. The cells were homogenized using a Dounce homogenizer (KONTES), and cytosolic and mitochondrial extracts were isolated as described previously .
Cells were lysed with a lysis buffer containing 50 mmol/L Tris (pH7.4), 0.5%NP-40, 0.01% SDS and a cocktail of protease inhibitors. Equal amounts of protein (30 μg) estimated by the BCA Protein Assay kit (Byotime) were separated by electrophoresis on 10% polyacrylamide gel and transferred to a PDVF membrane (Millipore). After blocking for 1 hour with 5% nonfat dry milk in TBST buffer containing 50 mmol/L Tris-HCl, 150 mmol/L NaCl and 0.1% Tween 20 (pH7.6) at room temperature, the blots were incubated overnight at 4°C with the specific primary antibody. Primary antibodies used were β-actin, IκBα, NF-κB, XIAP, c-IAP1, c-IAP2, PARP, AIF, Cytochrome c and Samc/Diablo (Cell Signaling Technology), Bax and Bcl-2 (Bioworld). Membranes were subsequently incubated with horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology) for 1 h at room temperature and developed using a chemiluminescent (ECL) reagent (Applygen Technologies). The results were scanned using Gel Imaging System (UVP Company) and measured using Gel-Pro Analyzer software (Media Cybernetics).
Data were presented as means ± SD. One-way ANOVA followed by LSD post-hoc test was used to assess the statistical significance of differences between groups. A value of P < 0.05 was considered to be statistically significant.
This work was supported by a Grant from the National Natural Science Foundation of China (No. 30972784).
- Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T: Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988,1(8594):1065–1067.PubMedView Article
- Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al.: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Sci 1986,234(4776):596–601.View Article
- Takahashi K, Sonoda S, Higashi K, Kondo T, Takahashi H, Takahashi M, Yamanishi K: Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 1989,63(7):3161–3163.PubMed
- Yoshikawa T: [Human herpesvirus 6 encephalitis]. Brain Nerve 2010,62(8):869–875.PubMed
- Niehusmann P, Mittelstaedt T, Bien CG, Drexler JF, Grote A, Schoch S, Becker AJ: Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia 2010,51(12):2478–2483.PubMedView Article
- Kakalacheva K, Munz C, Lunemann JD: Viral triggers of multiple sclerosis. Biochim Biophys Acta 2011,1812(2):132–140.PubMed
- Crawford JR, Santi MR, Thorarinsdottir HK, Cornelison R, Rushing EJ, Zhang H, Yao K, Jacobson S, Macdonald TJ: Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 2009,46(1):37–42.PubMedView Article
- Gardell JL, Dazin P, Islar J, Menge T, Genain CP, Lalive PH: Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity. J Clin Virol 2006,37(Suppl 1):S11–16.PubMedView Article
- Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F: The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 1998,4(5):486–494.PubMedView Article
- He J, McCarthy M, Zhou Y, Chandran B, Wood C: Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996,70(2):1296–1300.PubMed
- Kurokawa M, Kornbluth S: Caspases and kinases in a death grip. Cell 2009,138(5):838–854.PubMedView Article
- Green DR, Reed JC: Mitochondria and apoptosis. Sci 1998,281(5381):1309–1312.View Article
- Kumar S, Vaux DL: Apoptosis. A cinderella caspase takes center stage. Sci 2002,297(5585):1290–1291.View Article
- Danial NN, Korsmeyer SJ: Cell death: critical control points. Cell 2004,116(2):205–219.PubMedView Article
- Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000,102(1):43–53.PubMedView Article
- Jin Z, El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther 2005,4(2):139–163.PubMedView Article
- Gyrd-Hansen M, Meier P: IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 2010,10(8):561–574.PubMedView Article
- Safronetz D, Humar A, Tipples GA: Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR. J Virol Methods 2003,112(1–2):99–105.PubMedView Article
- Yasukawa M, Inoue Y, Ohminami H, Terada K, Fujita S: Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J Gen Virol 1998,79(Pt 1):143–147.PubMed
- Inoue Y, Yasukawa M, Fujita S: Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997,71(5):3751–3759.PubMed
- Ichimi R, Jin-no T, Ito M: Induction of apoptosis in cord blood lymphocytes by HHV-6. J Med Virol 1999,58(1):63–68.PubMedView Article
- Pugazhenthi S, Gilden DH, Nair S, McAdoo A, Wellish M, Brazeau E, Mahalingam R: Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression. J Virol 2009,83(18):9273–9282.PubMedView Article
- Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC: Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999,144(5):891–901.PubMedView Article
- Caroppi P, Sinibaldi F, Fiorucci L, Santucci R: Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem 2009,16(31):4058–4065.PubMed
- Yoon K, Jang HD, Lee SY: Direct interaction of Smac with NADE promotes TRAIL-induced apoptosis. Biochem Biophys Res Commun 2004,319(2):649–654.PubMedView Article
- Artus C, Boujrad H, Bouharrour A, Brunelle MN, Hoos S, Yuste VJ, Lenormand P, Rousselle JC, Namane A, England P, et al.: AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J 2010,29(9):1585–1599.PubMedView Article
- Cagnol S, Mansour A, Van Obberghen-Schilling E, Chambard JC: Raf-1 activation prevents caspase 9 processing downstream of apoptosome formation. J Signal Transduct 2011, 2011:834948.PubMed
- Adrain C, Creagh EM, Martin SJ: Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 2001,20(23):6627–6636.PubMedView Article
- Sarmento L, Tseggai T, Dhingra V, Fu ZF: Rabies virus-induced apoptosis involves caspase-dependent and caspase-independent pathways. Virus Res 2006,121(2):144–151.PubMedView Article
- Richter BW, Duckett CS: The IAP proteins: caspase inhibitors and beyond. Sci STKE 2000,2000(44):pe1.PubMedView Article
- Aydin C, Sanlioglu AD, Bisgin A, Yoldas B, Dertsiz L, Karacay B, Griffith TS, Sanlioglu S: NF-kappaB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC Cancer 2010, 10:584.PubMedView Article
- Li L, Gu B, Zhou F, Chi J, Wang F, Peng G, Xie F, Qing J, Feng D, Lu S, et al.: Human Herpesvirus 6 Suppresses T Cell Proliferation through Induction of Cell Cycle Arrest in Infected Cells in the G2/M Phase. J Virol 2011,85(13):6774–6783.PubMedView Article
- Malla R, Gopinath S, Alapati K, Gondi CS, Gujrati M, Dinh DH, Mohanam S, Rao JS: Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 2010, 5:e13731.PubMedView Article
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.